Evidence map›Paper›PMID 38581127›Full record

ReviewJournal of magnetic resonance imaging : JMRI2024

AI Applications to Breast MRI: Today and Tomorrow.

Roberto Lo Gullo, Joren Brunekreef, Eric Marcus, Lynn K Han, Sarah Eskreis-Winkler, Sunitha B Thakur, Ritse Mann, Kevin Groot Lipman, Jonas Teuwen, Katja Pinker

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of magnetic resonance imaging : JMRI, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Roberto Lo GulloDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.ORCID 0000-0001-6887-292X
Joren BrunekreefAI for Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.ORCID 0000-0002-5553-5016
Eric MarcusAI for Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.ORCID 0000-0002-3375-6248
Lynn K HanWeill Cornell Medical College, New York-Presbyterian Hospital, New York City, New York, USA.ORCID 0000-0002-1050-7679
Sarah Eskreis-WinklerDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.ORCID 0000-0003-2427-3532
Sunitha B ThakurDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.ORCID 0000-0001-8090-3696
Ritse MannAI for Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.ORCID 0000-0001-8111-1930
Kevin Groot LipmanAI for Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.ORCID 0000-0003-3651-2529
Jonas TeuwenAI for Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.ORCID 0000-0002-1825-1428
Katja PinkerDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.ORCID 0000-0002-2722-7331
Memorial Sloan Kettering Cancer Center · USRadboud University Nijmegen · NLThe Netherlands Cancer Institute · NLNewYork–Presbyterian Hospital · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

In breast imaging, there is an unrelenting increase in the demand for breast imaging services, partly explained by continuous expanding imaging indications in breast diagnosis and treatment. As the human workforce providing these services is not growing at the same rate, the implementation of artificial intelligence (AI) in breast imaging has gained significant momentum to maximize workflow efficiency and increase productivity while concurrently improving diagnostic accuracy and patient outcomes. Thus far, the implementation of AI in breast imaging is at the most advanced stage with mammography and digital breast tomosynthesis techniques, followed by ultrasound, whereas the implementation of AI in breast magnetic resonance imaging (MRI) is not moving along as rapidly due to the complexity of MRI examinations and fewer available dataset. Nevertheless, there is persisting interest in AI-enhanced breast MRI applications, even as the use of and indications of breast MRI continue to expand. This review presents an overview of the basic concepts of AI imaging analysis and subsequently reviews the use cases for AI-enhanced MRI interpretation, that is, breast MRI triaging and lesion detection, lesion classification, prediction of treatment response, risk assessment, and image quality. Finally, it provides an outlook on the barriers and facilitators for the adoption of AI in breast MRI. LEVEL OF EVIDENCE: 5 TECHNICAL EFFICACY: Stage 6.

Indexed as

Artificial IntelligenceBreastBreast NeoplasmsMagnetic Resonance ImagingFemaleHumansImage Interpretation, Computer-AssistedMammographyartificial intelligencebreastdeep learningmachine learningmagnetic resonance imaging

Identifiers

PMID38581127
PMCPMC11452568
OpenAlexW4394011806

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.